News

Algorithm offers unprecedented insight into copolymer block-length distributions
Analytical chemistry researchers at the University of Amsterdam's Van 't Hoff Institute for Molecular Sciences (HIMS) have ...
The Financial Express19h
Aurobindo Pharma gets European Commission’s nod to market cancer drug, Dazublys
CuraTeQ Biologics, a wholly owned subsidiary of the company dedicated to oncology and immunology segments, has received authorisation from the European authorities.
pharmaphorum1d
Biotech opportunities in North Carolina, with Kyle Touchstone and Laura Rowley
Touchstone and Rowley highlight why companies like Eli Lilly, Novo Nordisk, and Genentech are choosing to set up shop in ...
With potential $1.5 billion deal, Santa Cruz company rides biotech's new wave
Could synthetic macrocyclic peptides be the Next Big Thing to lift biotech? A potential $1.5 billion deal suggests things are ...
Neurofibromatosis Type 2 Market Set For Robust Growth Through 2034, Driven By Innovative Therapies And Growing Disease Awareness Delveinsight
Neurofibromatosis Type 2 Market Insight, Epidemiology And Market Forecast - 2034The Neurofibromatosis Type 2 treatment market is experiencin ...
Genentech ends ulcerative colitis study for drug from $700 million deal
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Ophthalmology Times6d
36-month results from phase 1/2a clinical study of RG6501 released
New findings reveal RG6501 cell therapy shows promising long-term visual improvements for geographic atrophy patients ...